HETEROGENEITY OF BIOCHEMICAL ACTIONS AMONG VASODILATORS

被引:32
作者
GREENSLADE, FC [1 ]
SCOTT, CK [1 ]
NEWQUIST, KL [1 ]
KRIDER, KM [1 ]
CHASIN, M [1 ]
机构
[1] ORTHO PHARMACEUT CORP, DIV BIOMED RES, RARITAN, NJ 08869 USA
关键词
D O I
10.1002/jps.2600710123
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:94 / 100
页数:7
相关论文
共 31 条
[1]  
AMER M S, 1975, Journal of Pharmaceutical Sciences, V64, P1, DOI 10.1002/jps.2600640106
[2]  
ANDERSSON R, 1973, ACTA PHARMACOL TOX, V32, P321
[3]  
Bar H P, 1974, Adv Cyclic Nucleotide Res, V4, P195
[4]  
Berridge M J, 1975, Adv Cyclic Nucleotide Res, V6, P1
[5]   VASODILATOR THERAPY - PHYSIOLOGIC APPROACH TO TREATMENT OF HEART-FAILURE [J].
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (06) :331-332
[6]  
CASE RM, 1976, STIMULUS SECRETION C, P33
[7]  
CHASIN M, 1972, METHODS CYCLIC NUCLE, P69
[8]   PHARMACOLOGIC BASIS OF ANTIHYPERTENSIVE THERAPY - ROLE OF VASODILATOR DRUGS [J].
CHIDSEY, CA ;
GOTTLIEB, TB .
PROGRESS IN CARDIOVASCULAR DISEASES, 1974, 17 (02) :99-113
[9]  
COFFMAN JD, 1979, NEW ENGL J MED, V300, P713
[10]  
COHN JN, 1977, NEW ENGL J MED, V297, P254